发现了SARS-CoV-2主要蛋白酶的第一类PROTAC降解剂
bioRxiv : the preprint server for biology
|October 9, 2023
概括
新的PROTAC技术针对SARS-CoV-2主要蛋白酶 (M Pro) 进行COVID-19治疗. 这种方法降解病毒蛋白质,为有效的抗病毒药物开发提供了传统抑制剂的有希望的替代方案.
科学领域:
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
- 分子生物学分子生物学
背景情况:
- 包括SARS-CoV-2在内的冠状病毒 (CoV) 已经造成了重大的全球健康危机.
- 主蛋白酶 (M Pro) 对于Cov复制至关重要,也是抗病毒疗法的关键标.
- 现有的MPro抑制剂面临着耐药性和毒性等挑战.
研究的目的:
- 开发新的小分子抗病毒药物,针对SARS-CoV-2 M Pro,使用蛋白质溶解向喜梅拉 (PROTAC) 技术.
- 研究向蛋白质降解作为下一代抗病毒战略的潜力.
主要方法:
- 利用PROTAC技术创建双功能分子,将MPro抑制剂与E3酶连接体 (CRBN) 连接起来.
- 测试了包括MDP2在内的新型化合物的有效性,在细胞系中降解M Pro.
- 评估了感染细胞中针对SARS-CoV-2的化合物的抗病毒活性.
主要成果:
- 开发出能够抑制和降解SARS-CoV-2 M Pro 的PROTAC化合物.
- 在293T细胞中,MDP2通过CRBN介导的,蛋白酶依赖的途径有效降低了MPro蛋白水平.
- 在感染的A549-ACE2细胞中,MDP2表现出显著的抗SARS-CoV-2活性.
结论:
- 通过PROTAC介导的SARS-CoV-2M的向降解,是COVID-19药物发现的可行和有前途的战略.
- 这种方法为传统抗病毒抑制剂的局限性提供了潜在的解决方案.
- 突出了蛋白质降解在开发广谱抗病毒药物方面的潜力.
相关概念视频
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...


